MAR 04, 2017 2:05 PM PST

Thymic Tumors Trigger Newly Discovered Immune Disorder

WRITTEN BY: Kara Marker

Six years ago, researchers from Kobe University discovered a new condition caused by an autoimmune reaction against PIT-1, a pituitary-specific transcription factor that is primarily involved in producing growth hormone (GH), thyroid stimulation hormone (TSH), and prolactin (PRL). This week, the same scientists uncovered evidence showing that the condition is caused by tumors in the thymic gland.

Credit: Kobe University

During their discovery of the new autoimmune disease, Kobe University researchers found anti-PIT-1 antibodies in the blood of patients with the apparent disease. Accordingly, they called the disease “anti-PIT-1 antibody syndrome,” but at the time they did not know what was causing the immune system to become intolerant to the PIT-1 transcription factor.

Their new study, published in the journal Scientific Reports, revealed the one component consistently present in a variety of anti-PIT-1 antibody syndrome cases: the detection of a thymoma, a tumor originating in the thymic gland. PIT-1 was found to be abnormally expressed within the detected thymomas, and cytotoxic T cells of the immune system were mistakenly designed to target PIT-1. Together, these two events triggered an autoimmune reaction characteristic of what the scientists called anti-PIT-1 antibody syndrome.

Hypopituitarism, which appears to occur as a result of anti-PIT-1 antibody syndrome, dampens the activity of the pituitary gland, which is located at the base of the brain and regulates several hormones. The recent discovery from Kobe University offers researchers an opportunity to develop new treatments for both anti-PIT-1 antibody syndrome and similar autoimmune diseases.

"Around 20% of hypopituitarism cases are caused by unknown factors. This discovery has clarified one of the causes," said Associate Professor Takahashi. "We hope that this discovery will contribute to more effective diagnosis and treatment for patients suffering from autoimmune pituitary diseases, hypopituitarism, and thymomas."

Source: Kobe University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 10, 2020
Immunology
FEB 10, 2020
How Cancer Evades the Immune System Time and Time Again
Scientists discovered a new mechanism by which cancer cells evade the immune system to further their own agenda: invade, ...
FEB 26, 2020
Neuroscience
FEB 26, 2020
Immunotherapy Could Be Used to Treat Traumatic Brain Injury
Video:  Further explaination of microglia and their various functions.  Traumatic Brain Injuries are physical ...
MAR 19, 2020
Drug Discovery & Development
MAR 19, 2020
Does Sucking Zinc Lozenges Help Fight off Coronavirus?
As panic is spreading over the novel coronavirus, the time is ripe for both misinformation and disinformation to thrive. ...
MAR 28, 2020
Drug Discovery & Development
MAR 28, 2020
Could the Blood of Coronavirus Survivors Save Lives?
As the search for a treatment for coronavirus continues, a perhaps obscure-sounding candidate has begun to make headline ...
APR 22, 2020
Immunology
APR 22, 2020
Scientists Engineer Custom Antiviral Receptors to Fight COVID-19
The best offense may be a good defense in the fight against COVID-19. Researchers from the Duke-NUS Medical School are e ...
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
Loading Comments...